{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:30:37Z","timestamp":1787502637928,"version":"build-2736575974"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Public Health Service","award":["R01 NS108773"],"award-info":[{"award-number":["R01 NS108773"]}]},{"name":"Public Health Service","award":["F32 CA224593"],"award-info":[{"award-number":["F32 CA224593"]}]},{"name":"Public Health Service","award":["K99 CA263021"],"award-info":[{"award-number":["K99 CA263021"]}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1KL2TR002554"],"award-info":[{"award-number":["1KL2TR002554"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malignant gliomas commandeer dense inflammatory infiltrates with glioma-associated macrophages and microglia (GAMM) promoting immune suppression, evasion, and tumor progression. Like all cells in the mononuclear phagocytic system, GAMM constitutively express the poliovirus receptor, CD155. Besides myeloid cells, CD155 is widely upregulated in the neoplastic compartment of malignant gliomas. Intratumor treatment with the highly attenuated rhino:poliovirus chimera, PVSRIPO, yielded long-term survival with durable radiographic responses in patients with recurrent glioblastoma (Desjardins et al. New England Journal of Medicine, 2018). This scenario raises questions about the contributions of myeloid versus neoplastic cells to polio virotherapy of malignant gliomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated PVSRIPO immunotherapy in immunocompetent mouse brain tumor models with blinded, board-certified neuropathologist review, a range of neuropathological, immunohistochemical, and immunofluorescence analyses, and RNAseq of the tumor region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PVSRIPO treatment caused intense engagement of the GAMM infiltrate associated with substantial, but transient tumor regression. This was accompanied by marked microglia activation and proliferation in normal brain surrounding the tumor, in the ipsilateral hemisphere and extending into the contralateral hemisphere. There was no evidence for lytic infection of malignant cells. PVSRIPO-instigated microglia activation occurred against a backdrop of sustained innate antiviral inflammation, associated with induction of the Programmed Cell Death Ligand 1 (PD-L1) immune checkpoint on GAMM. Combining PVSRIPO with PD1\/PD-L1 blockade led to durable remissions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our work implicates GAMM as active drivers of PVSRIPO-induced antitumor inflammation and reveals profound and widespread neuroinflammatory activation of the brain-resident myeloid compartment by PVSRIPO.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noad052","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T16:55:18Z","timestamp":1677516918000},"page":"1631-1643","source":"Crossref","is-referenced-by-count":27,"title":["Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS"],"prefix":"10.1093","volume":"25","author":[{"given":"Yuanfan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pathology, Duke University School of Medicine , Durham, North Carolina , USA"},{"name":"Department of Neurosurgery, Duke University Medical School , Durham, NC , USA"},{"name":"Department of Neurosurgery, University of Alabama at Birmingham , Birmingham, Alabama , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Duke University Medical School , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Duke University School of Medicine , Durham, North Carolina , USA"},{"name":"Department of Neurosurgery, Duke University Medical School , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Duke University Medical School , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Mohme","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center Hamburg-Eppendorf , Hamburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reb","family":"Kornahrens","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Duke University Medical School , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darell D","family":"Bigner","sequence":"additional","affiliation":[{"name":"Department of Pathology, Duke University School of Medicine , Durham, North Carolina , USA"},{"name":"Department of Neurosurgery, Duke University Medical School , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Ashley","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Duke University Medical School , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle Y","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Duke University School of Medicine , Durham, North Carolina , USA"},{"name":"Department of Neurosurgery, Duke University Medical School , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gromeier","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Duke University Medical School , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"issue":"3","key":"2023090516430770900_CIT0001","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3171\/jns.1979.50.3.0305","article-title":"Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors","volume":"50","author":"Morantz","year":"1979","journal-title":"J Neurosurg."},{"issue":"6005","key":"2023090516430770900_CIT0002","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science."},{"issue":"4","key":"2023090516430770900_CIT0003","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","article-title":"Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion","volume":"21","author":"Huang","year":"2018","journal-title":"Nat Neurosci."},{"issue":"4","key":"2023090516430770900_CIT0004","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J Clin Invest."},{"issue":"6","key":"2023090516430770900_CIT0005","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/brain\/aww355","article-title":"Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis","volume":"140","author":"Poon","year":"2017","journal-title":"Brain."},{"issue":"2","key":"2023090516430770900_CIT0006","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJMoa1716435","article-title":"Recurrent glioblastoma treated with recombinant poliovirus","volume":"379","author":"Desjardins","year":"2018","journal-title":"N Engl J Med."},{"issue":"5","key":"2023090516430770900_CIT0007","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(89)90690-9","article-title":"Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily","volume":"56","author":"Mendelsohn","year":"1989","journal-title":"Cell."},{"issue":"14","key":"2023090516430770900_CIT0008","doi-asserted-by":"crossref","first-page":"e02310","DOI":"10.1128\/JVI.02310-16","article-title":"Pathogenic Events in a nonhuman primate model of oral poliovirus infection leading to paralytic poliomyelitis","volume":"91","author":"Shen","year":"2017","journal-title":"J Virol."},{"issue":"3159","key":"2023090516430770900_CIT0009","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.122.3159.105","article-title":"Emerging concept of poliomyelitis infection","volume":"122","author":"Bodian","year":"1955","journal-title":"Science."},{"issue":"3209","key":"2023090516430770900_CIT0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.123.3209.1151","article-title":"Pathogenesis of poliomyelitis; reappraisal in the light of new data","volume":"123","author":"Sabin","year":"1956","journal-title":"Science."},{"issue":"1","key":"2023090516430770900_CIT0011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/JVI.79.1.401-409.2005","article-title":"Dendritic cells and macrophages are productively infected by poliovirus","volume":"79","author":"Wahid","year":"2005","journal-title":"J Virol."},{"issue":"6","key":"2023090516430770900_CIT0012","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1073\/pnas.93.6.2370","article-title":"Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants","volume":"93","author":"Gromeier","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2023090516430770900_CIT0013","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/JVI.06427-11","article-title":"Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis","volume":"86","author":"Dobrikova","year":"2012","journal-title":"J Virol."},{"issue":"408","key":"2023090516430770900_CIT0014","doi-asserted-by":"crossref","first-page":"eaan4220-2","DOI":"10.1126\/scitranslmed.aan4220","article-title":"Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs","volume":"9","author":"Brown","year":"2017","journal-title":"Sci Transl Med."},{"issue":"1","key":"2023090516430770900_CIT0015","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41467-021-22088-1","article-title":"Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling","volume":"12","author":"Brown","year":"2021","journal-title":"Nat Commun."},{"issue":"1","key":"2023090516430770900_CIT0016","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41467-019-13939-z","article-title":"Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity","volume":"11","author":"Mosaheb","year":"2020","journal-title":"Nat Commun."},{"issue":"12","key":"2023090516430770900_CIT0017","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","article-title":"New tools for studying microglia in the mouse and human CNS","volume":"113","author":"Bennett","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"2023090516430770900_CIT0018","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1369\/jhc.6A7156.2007","article-title":"Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry","volume":"55","author":"Ahmed","year":"2007","journal-title":"J Histochem Cytochem."},{"issue":"7","key":"2023090516430770900_CIT0019","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/JVI.80.7.3310-3321.2006","article-title":"Competitive translation efficiency at the picornavirus type 1 internal ribosome entry site facilitated by viral cis and trans factors","volume":"80","author":"Dobrikova","year":"2006","journal-title":"J Virol."},{"issue":"2","key":"2023090516430770900_CIT0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF03159989","article-title":"Ganglioside distribution in murine neural tumors","volume":"17","author":"Seyfried","year":"1992","journal-title":"Mol Chem Neuropathol."},{"issue":"12","key":"2023090516430770900_CIT0021","first-page":"1309","article-title":"Standardization of an orthotopic mouse brain tumor model following transplantation of CT-2A astrocytoma cells","volume":"22","author":"Martinez-Murillo","year":"2007","journal-title":"Histol Histopathol."},{"key":"2023090516430770900_CIT0022","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1479-5876-12-107","article-title":"Immunocompetent murine models for the study of glioblastoma immunotherapy","volume":"12","author":"Oh","year":"2014","journal-title":"J Transl Med."},{"issue":"12","key":"2023090516430770900_CIT0023","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.5858\/arpa.2016-0580-OA","article-title":"Validation of an immunohistochemistry assay for detection of cd155, the poliovirus receptor, in malignant gliomas","volume":"141","author":"Chandramohan","year":"2017","journal-title":"Arch Pathol Lab Med."},{"issue":"3","key":"2023090516430770900_CIT0024","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1073\/pnas.88.3.951","article-title":"Transgenic mice susceptible to poliovirus","volume":"88","author":"Koike","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2023090516430770900_CIT0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.celrep.2018.09.003","article-title":"Type I interferon receptor signaling of neurons and astrocytes regulates microglia activation during viral encephalitis","volume":"25","author":"Chhatbar","year":"2018","journal-title":"Cell Rep"},{"issue":"6","key":"2023090516430770900_CIT0026","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"1","key":"2023090516430770900_CIT0027","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"issue":"5007","key":"2023090516430770900_CIT0028","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.1851332","article-title":"Experimental therapy of human glioma by means of a genetically engineered virus mutant","volume":"252","author":"Martuza","year":"1991","journal-title":"Science."},{"issue":"19","key":"2023090516430770900_CIT0029","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1158\/0008-5472.CAN-07-1063","article-title":"Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses","volume":"67","author":"Fulci","year":"2007","journal-title":"Cancer Res."},{"key":"2023090516430770900_CIT0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-med-050715-104655","article-title":"Recombinant poliovirus for cancer immunotherapy","volume":"69","author":"Gromeier","year":"2018","journal-title":"Annu Rev Med."},{"issue":"3","key":"2023090516430770900_CIT0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1215\/S1152851703000577","article-title":"Poliovirus receptor CD155-targeted oncolysis of glioma","volume":"6","author":"Merrill","year":"2004","journal-title":"Neuro Oncol"},{"issue":"19","key":"2023090516430770900_CIT0032","doi-asserted-by":"crossref","first-page":"e00879","DOI":"10.1128\/JVI.00879-18","article-title":"Engineered oncolytic poliovirus PVSRIPO subverts MDA5-dependent innate immune responses in cancer cells","volume":"92","author":"Walton","year":"2018","journal-title":"J Virol."},{"issue":"22","key":"2023090516430770900_CIT0033","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.1128\/JVI.01883-14","article-title":"Induction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine\/arginine-rich protein kinase","volume":"88","author":"Brown","year":"2014","journal-title":"J Virol."},{"issue":"22","key":"2023090516430770900_CIT0034","doi-asserted-by":"crossref","first-page":"13149","DOI":"10.1128\/JVI.01884-14","article-title":"Mitogen-activated protein kinase-interacting kinase regulates mTOR\/AKT signaling and controls the serine\/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated translation and viral oncolysis","volume":"88","author":"Brown","year":"2014","journal-title":"J Virol."},{"issue":"2","key":"2023090516430770900_CIT0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41423-020-00620-5","article-title":"The roles of microglia in viral encephalitis: from sensome to therapeutic targeting","volume":"18","author":"Chhatbar","year":"2021","journal-title":"Cell Mol Immunol."},{"key":"2023090516430770900_CIT0036","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2014.05.049","article-title":"TLR signaling controls lethal encephalitis in WNV-infected brain","volume":"1574","author":"Sabouri","year":"2014","journal-title":"Brain Res."},{"issue":"5","key":"2023090516430770900_CIT0037","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/glia.24144","article-title":"MAC2 is a long-lasting marker of peripheral cell infiltrates into the mouse CNS after bone marrow transplantation and coronavirus infection","volume":"70","author":"Hohsfield","year":"2022","journal-title":"Glia."},{"issue":"48","key":"2023090516430770900_CIT0038","doi-asserted-by":"crossref","first-page":"eabb1817","DOI":"10.1126\/sciimmunol.abb1817","article-title":"T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection","volume":"5","author":"Moseman","year":"2020","journal-title":"Sci Immunol."},{"issue":"7","key":"2023090516430770900_CIT0039","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/JVI.80.7.3147-3156.2006","article-title":"Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76","volume":"80","author":"Merrill","year":"2006","journal-title":"J Virol."},{"issue":"2","key":"2023090516430770900_CIT0040","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/JVI.73.2.958-964.1999","article-title":"Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence","volume":"73","author":"Gromeier","year":"1999","journal-title":"J Virol."},{"issue":"1","key":"2023090516430770900_CIT0041","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11060-020-03483-y","article-title":"Immune suppression in gliomas","volume":"151","author":"Grabowski","year":"2021","journal-title":"J Neurooncol."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad052\/49803438\/noad052.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/9\/1631\/51360767\/noad052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/9\/1631\/51360767\/noad052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T12:49:40Z","timestamp":1693918180000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/25\/9\/1631\/7067953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,3,2]]},"published-print":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad052","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2023,3,2]]}}}